Impact of baseline steroids on the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma

doi:10.4251/wjgo.v16.i9.3887

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (94)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-5)

Tables (1-2)

Sum=91

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

Sep 15, 2024 (publication date) through Sep 10, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3887-3897
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3887

Full Size Figure Download Figure

Figure 2 Immunochemotherapy regimen and pre-treatment medications. This bar chart shows the distribution of various drug combinations used in neoadjuvant immunochemotherapy for patients with locally advanced esophageal squamous cell carcinoma who were pre-treated with either dexamethasone or antihistamines.

Citation: Huang YH, Yang GZ, Chen HG, Li XJ, Wu YH, Zhang K, Xu JN, Zhang J. Impact of baseline steroids on the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma. World J Gastrointest Oncol 2024; 16(9): 3887-3897
URL: https://www.wjgnet.com/1948-5204/full/v16/i9/3887.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i9.3887